Cargando…

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA

BACKGROUND: Molecular analysis of circulating tumour DNA (ctDNA) is becoming increasingly important in clinical treatment decisions. A pilot External Quality Assessment (EQA) scheme for ctDNA analysis was organized by four European EQA providers under the umbrella organization IQN Path, in order to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keppens, Cleo, Dequeker, Elisabeth M. C., Patton, Simon J., Normanno, Nicola, Fenizia, Francesca, Butler, Rachel, Cheetham, Melanie, Fairley, Jennifer A., Williams, Hannah, Hall, Jacqueline A., Schuuring, Ed, Deans, Zandra C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085634/ https://www.ncbi.nlm.nih.gov/pubmed/30092778 http://dx.doi.org/10.1186/s12885-018-4694-x

Ejemplares similares

IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing
por: Deans, Zandra C., et al.
Publicado: (2019)

Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey
por: Deans, Zandra C., et al.
Publicado: (2017)

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer
por: Fairley, Jennifer A., et al.
Publicado: (2022)

External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys
por: Keppens, Cleo, et al.
Publicado: (2020)

Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological Biomarkers
por: Keppens, Cleo, et al.
Publicado: (2020)

RAS screening in colorectal cancer: a comprehensive analysis of the results from the UK NEQAS colorectal cancer external quality assurance schemes (2009–2016)
por: Richman, Susan D., et al.
Publicado: (2017)

Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path)
por: Fenizia, Francesca, et al.
Publicado: (2021)

Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories
por: Tack, Véronique, et al.
Publicado: (2018)

Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?
por: Keppens, Cleo, et al.
Publicado: (2019)

A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer
por: Keppens, Cleo, et al.
Publicado: (2018)

Biomarker testing in oncology – Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL
por: Dufraing, K., et al.
Publicado: (2020)

Ensuring high standards for the delivery of NIPT world‐wide: Development of an international external quality assessment scheme
por: Deans, Zandra C., et al.
Publicado: (2019)

Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL
por: Deans, Zandra C, et al.
Publicado: (2016)

How close are we to standardised extended RAS gene mutation testing? The UK NEQAS evaluation
por: Richman, Susan D, et al.
Publicado: (2017)

Guidance for laboratories performing molecular pathology for cancer patients
por: Cree, Ian A, et al.
Publicado: (2014)

The Significance of External Quality Assessment Schemes for Molecular Testing in Clinical Laboratories
por: Laudus, Nele, et al.
Publicado: (2022)

Quality to rely on: meeting report of the 5th Meeting of External Quality Assessment, Naples 2016
por: van Krieken, Han, et al.
Publicado: (2016)

Results of the UK NEQAS for Molecular Genetics reference sample analysis
por: Richman, Susan D, et al.
Publicado: (2018)

PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation
por: Keppens, Cleo, et al.
Publicado: (2020)

Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect
por: Keppens, Cleo, et al.
Publicado: (2021)

Validation of the Oncomine(™) focus panel for next-generation sequencing of clinical tumour samples
por: Williams, Hannah L., et al.
Publicado: (2018)

The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization
por: Tembuyser, Lien, et al.
Publicado: (2014)

European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects
por: Keppens, Cleo, et al.
Publicado: (2019)

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing
por: Patton, S, et al.
Publicado: (2014)

External quality assessment for EGFR mutations in Italy: improvements in performances over the time
por: Normanno, Nicola, et al.
Publicado: (2017)

Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples
por: Keppens, Cleo, et al.
Publicado: (2020)

The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences
por: Normanno, Nicola, et al.
Publicado: (2015)

Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management
por: Penault-Llorca, Frédérique, et al.
Publicado: (2022)

Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment
por: Penault-Llorca, Frédérique, et al.
Publicado: (2022)

Recommendations for reporting results of diagnostic genomic testing
por: Deans, Zandra C., et al.
Publicado: (2022)

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
por: van der Leest, Paul, et al.
Publicado: (2020)

Recommended practice for laboratory reporting of non‐invasive prenatal testing of trisomies 13, 18 and 21: a consensus opinion
por: Deans, Zandra C., et al.
Publicado: (2017)

External Quality Assessment Schemes in Latin America
por: Migliarino, Gabriel Alejandro
Publicado: (2015)

One byte at a time: evidencing the quality of clinical service next-generation sequencing for germline and somatic variants
por: Gutowska-Ding, Maria Weronika, et al.
Publicado: (2019)

Interpretation in Clinical Biochemistry: An External Quality Assurance Scheme
por: Challand, Gordon, et al.
Publicado: (2004)

Circulating tumour DNA in colorectal cancer management
por: Cohen, Ryan, et al.
Publicado: (2023)

Novel external bunch injection scheme for laser wakefield acceleration
por: Khachatrian, A G, et al.
Publicado: (2005)

Novel External Bunch Injection Scheme for Laser Wakefield Acceleration
por: Khachatrian, A G, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_brj57qaa77c9rn2gb5gru89pb2